Coxsackievirus entry across epithelial tight junctions requires occludin and the small GTPases Rab34 and Rab5.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Author(s): Coyne CB;Coyne CB; Shen L; Turner JR; Bergelson JM
  • Source:
    Cell host & microbe [Cell Host Microbe] 2007 Sep 13; Vol. 2 (3), pp. 181-92.
  • Publication Type:
    Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • Language:
    English
  • Additional Information
    • Source:
      Publisher: Cell Press Country of Publication: United States NLM ID: 101302316 Publication Model: Print Cited Medium: Internet ISSN: 1934-6069 (Electronic) Linking ISSN: 19313128 NLM ISO Abbreviation: Cell Host Microbe Subsets: MEDLINE
    • Publication Information:
      Original Publication: Cambridge, Mass. : Cell Press
    • Subject Terms:
    • Abstract:
      The major group B coxsackievirus (CVB) receptor is a component of the epithelial tight junction (TJ), a protein complex that regulates the selective passage of ions and molecules across the epithelium. CVB enters polarized epithelial cells from the TJ, causing a transient disruption of TJ integrity. Here we show that CVB does not induce major reorganization of the TJ, but stimulates the specific internalization of occludin-a TJ integral membrane component-within macropinosomes. Although occludin does not interact directly with virus, depletion of occludin prevents CVB entry into the cytoplasm and inhibits infection. Both occludin internalization and CVB entry require caveolin but not dynamin; both are blocked by inhibitors of macropinocytosis and require the activity of Rab34, Ras, and Rab5, GTPases known to regulate macropinocytosis. Thus, CVB entry depends on occludin and occurs by a process that combines aspects of caveolar endocytosis with features characteristic of macropinocytosis.
    • Comments:
      Comment in: Cell Host Microbe. 2007 Sep 13;2(3):143-6. doi: 10.1016/j.chom.2007.08.004. (PMID: 18005729)
    • References:
      Nat Rev Mol Cell Biol. 2007 Mar;8(3):185-94. (PMID: 17318224)
      Mol Biol Cell. 2002 Apr;13(4):1227-37. (PMID: 11950934)
      Exp Cell Res. 1999 Dec 15;253(2):629-36. (PMID: 10585286)
      J Cell Biol. 1993 Aug;122(3):553-63. (PMID: 8101525)
      Immunology. 2005 Dec;116(4):513-24. (PMID: 16313365)
      J Biol Chem. 1999 Sep 3;274(36):25708-17. (PMID: 10464308)
      Science. 1986 Sep 5;233(4768):1061-8. (PMID: 3090687)
      Proc Natl Acad Sci U S A. 2001 Dec 18;98(26):15191-6. (PMID: 11734628)
      J Cell Biol. 1997 Jun 16;137(6):1393-401. (PMID: 9182670)
      Cell. 2004 Sep 17;118(6):767-80. (PMID: 15369675)
      Cell Cycle. 2005 Nov;4(11):1599-607. (PMID: 16205123)
      J Cell Sci. 1995 Feb;108 ( Pt 2):609-19. (PMID: 7769005)
      J Biol Chem. 2004 Nov 12;279(46):48079-84. (PMID: 15364909)
      Adv Drug Deliv Rev. 2005 Apr 25;57(6):883-917. (PMID: 15820558)
      EMBO J. 2002 Oct 1;21(19):5017-25. (PMID: 12356718)
      J Cell Biol. 1999 Oct 4;147(1):195-204. (PMID: 10508866)
      Nature. 2004 May 20;429(6989):309-14. (PMID: 15152255)
      Science. 1997 Feb 28;275(5304):1320-3. (PMID: 9036860)
      J Biol Chem. 2000 Sep 22;275(38):29816-22. (PMID: 10887180)
      Cell. 2006 Jan 13;124(1):119-31. (PMID: 16413486)
      J Cell Biol. 2002 Sep 16;158(6):1119-31. (PMID: 12221069)
      J Biol Chem. 2005 Jan 21;280(3):2220-8. (PMID: 15528189)
      J Virol. 2001 Nov;75(22):11166-77. (PMID: 11602756)
      Cell. 1992 Aug 7;70(3):401-10. (PMID: 1643658)
      PLoS Biol. 2004 Sep;2(9):E261. (PMID: 15328530)
      J Cell Biol. 1989 Dec;109(6 Pt 1):2731-9. (PMID: 2556406)
      Annu Rev Microbiol. 2002;56:677-702. (PMID: 12142481)
      Nat Cell Biol. 2001 May;3(5):473-83. (PMID: 11331875)
      Biochem J. 2006 Jan 1;393(Pt 1):69-77. (PMID: 16134968)
      J Virol. 2002 Jul;76(13):6689-700. (PMID: 12050382)
      Curr Biol. 2000 Jul 13;10(14):839-48. (PMID: 10899002)
      Mol Biol Cell. 2005 Sep;16(9):3919-36. (PMID: 15958494)
      Cell. 2001 Feb 9;104(3):441-51. (PMID: 11239401)
      Nature. 2007 Apr 12;446(7137):801-5. (PMID: 17325668)
      J Cell Sci. 1998 Mar;111 ( Pt 6):825-32. (PMID: 9472010)
      Nat Cell Biol. 2006 Feb;8(2):113-23. (PMID: 16429128)
      J Cell Sci. 2006 Feb 15;119(Pt 4):605-14. (PMID: 16467569)
      FEBS Lett. 2003 Mar 13;538(1-3):85-8. (PMID: 12633858)
      Am J Physiol. 1997 Dec;273(6):C1859-67. (PMID: 9435490)
      Trends Cell Biol. 1995 Nov;5(11):424-8. (PMID: 14732047)
      J Cell Sci. 2000 May;113 ( Pt 10):1771-81. (PMID: 10769208)
      Nat Rev Mol Cell Biol. 2001 Feb;2(2):107-17. (PMID: 11252952)
      J Virol. 1984 Mar;49(3):635-40. (PMID: 6321753)
      Traffic. 2006 May;7(5):589-603. (PMID: 16643281)
      Science. 1998 Jun 5;280(5369):1618-20. (PMID: 9616127)
      Science. 2000 Aug 4;289(5480):732-3. (PMID: 10950716)
      Am J Physiol Cell Physiol. 2004 Jun;286(6):C1213-28. (PMID: 15151915)
      J Biol Chem. 2003 Feb 7;278(6):4063-71. (PMID: 12446704)
      Am J Physiol Cell Physiol. 2005 Jun;288(6):C1231-41. (PMID: 15689410)
      Science. 1998 Oct 30;282(5390):938-41. (PMID: 9794763)
    • Grant Information:
      R01 DK061931 United States DK NIDDK NIH HHS; R01 DK061931-06 United States DK NIDDK NIH HHS; R01AI5228 United States AI NIAID NIH HHS
    • Accession Number:
      0 (Caveolins)
      0 (Membrane Proteins)
      0 (OCLN protein, human)
      0 (Occludin)
      0 (ras GTPase-Activating Proteins)
      EC 3.6.1.- (RAB39A protein, human)
      EC 3.6.5.2 (rab GTP-Binding Proteins)
      EC 3.6.5.2 (rab5 GTP-Binding Proteins)
      EC 3.6.5.5 (Dynamins)
    • Publication Date:
      Date Created: 20071117 Date Completed: 20071211 Latest Revision: 20211020
    • Publication Date:
      20250114
    • Accession Number:
      PMC2719558
    • Accession Number:
      10.1016/j.chom.2007.07.003
    • Accession Number:
      18005733